Neuroregulators for the Treatment of Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities. | MicrobiomeTrials← Back to trialsNCT06778824
Neuroregulators for the Treatment of Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities.
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2024-04-02Est. Completion: 2026-12-31
Enrollment target: 610 participants Locations- Hualien Tzu Chi Hospital,Buddhist Tzu Chi Medical Foundation, Hualien City, Taiwan
Other microbiome trials you might be interested in
MigraineReflexologyPainAnxietyKinesiophobiaPostural Control
This prospective randomized controlled study aims to investigate the effects of foot massage on pain, anxiety, kinesioph…
Karabük, Turkey (Türkiye)Completed Aug 31, 2026
Trisomy 8 MosaicismTrisomy 8 Associated Autoinflammatory DiseaseMucosal Ulcerations
Background:
Trisomy 8 mosaicism is a genetic disorder that can increase inflammation in the body. Symptoms include feve…
Bethesda, United StatesEst. completion May 1, 2056
Healthy Volunteer
Background:
As people age, the cells in the pancreas that produce insulin begin to release less of this hormone, and le…
Baltimore, United StatesEst. completion Mar 31, 2027